Search PubMed⌕ Search

Biomedical subjects

M Gordin

Publications and source records attributed to M Gordin.

9 recordsLinked to original sources

Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis.

Endothelin-1 (ET)-1 within the corpus luteum (CL) is rapidly up-regulated during natural or PGF(2 alpha)-induced luteolysis; however, such an increase was not observed at early luteal stage, when the CL is refractory to PGF(2 alpha). The mature and active form of ET-1 is derived from the inactive intermediate peptide, big ET-1, by ET-converting enzyme (ECE)-1. This study therefore examined the developmental and cell-specific expression of ECE-1 in bovine CL. A significant, 4-fold, elevation in ECE-1 expression (mRNA and protein levels) occurred during the transition of the CL from early to midluteal phase. Analysis using in-situ hybridization and enriched luteal cell subpopulations showed that both steroidogenic and endothelial cells of the CL expressed high levels of ECE-1 mRNA; prepro ET-1 mRNA, on the other hand, was only expressed by resident endothelial cells. These data suggest that luteal parenchymal and endothelial cells may cooperate in the biosynthesis of mature bioactive ET-1. In the mature CL, ECE-1 mRNA increase occurred both in steroidogenic and endothelial cells and was accompanied by a significant rise in ET-1 peptide. However, in contrast to ECE-1, prepro ET-1 mRNA levels were similar in early and midluteal-phase CL. Low ECE-1 levels during the early luteal phase, restricting the production of active ET-1, may explain why the immature CL is able to withstand PGF(2 alpha)-induced luteolysis.

Animals↗

Semipermeable polyurethane membrane as an artificial skin for the premature neonate.

A thin and semipermeable polyurethane membrane adherently applied to premature neonates as an artificial skin was investigated as an atraumatic surface barrier sufficient to reduce transepidermal water loss without inhibiting natural infant skin development during the first few days of life. A sample group of 18 neonates (birth weight [mean +/- SEM] 1.39 +/- 0.12 kg, gestation [mean +/- SEM] 31 +/- 1 weeks) received two 3 X 3-cm polyurethane patches adherent over the chest and abdomen. Transepidermal water loss was measured before and after application and after membrane removal. During longitudinal study, seven infants were treated day 1 through day 4 of life and were evaluated for skin integrity 24 hours after patch removal on day 5. Polyurethane membranes produced an acute and significant reduction in transepidermal water loss for the 18 subjects: 21.1 +/- 2.0 g/m2/h before application v 10.5 +/- 1.4 g/m2/h with membranes in place (P less than .001). Immediately after patch removal, transepidermal loss returned to 22.8 +/- 3.0 g/m2/h. Throughout the first four days of life, daily measurements of water loss were significantly less: 53% to as much as 72% reduction from polyurethane-covered sites when compared with adjacent naked skin. After polyurethane membrane removal, skin development of transepidermal barrier function was comparable over both sites. Dressings did not lose adhesive or plastic properties during an extended time in either radiant warmer or incubator environments, electronic monitoring through membranes was not impeded, and adhesive injuries were not observed. An adherent, semipermeable polyurethane membrane may be effective as an atraumatic artificial barrier to prevent large transepidermal water loss and protect the skin of the premature neonate.

Body Temperature Regulation↗